Metastatic colorectal cancer patients with KRAS mutated tumors and high plasma TIMP-1 level seems to benefit from EGFR-inhibition therapy: results from the NORDIC VII Study

Activity: Talks and presentationsTalks and presentations in private or public companies

Period2014
Event titleDansk Selskab for Cancerforskning Årsmøde 2014
Event typeConference
LocationDenmarkShow on map